Puma Biotechnology (PBYI) Return on Capital Employed Growth (3y) (2015 - 2026)
Puma Biotechnology (PBYI) Return on Capital Employed Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,719.23 Bn | 65,718.94 Bn | - | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.85 Bn | 467.06 Bn | 1.35 Bn | 4,893.00 |
| 5 | Vertex Pharmaceuticals | 122.29 Bn | 115.04 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.28 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.47 Bn | 959.66 Mn | 4,853.00 |
| 10 | Puma Biotechnology | 411.08 Mn | 372.80 Mn | 34.39 Mn | 246.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 246.00 |
| Dec 31, 2025 | 1,122.00 |
| Sep 30, 2025 | 1,381.00 |
| Jun 30, 2025 | 3,301.00 |
| Mar 31, 2025 | 4,559.00 |
| Dec 31, 2024 | 2,442.00 |
| Sep 30, 2024 | 4,469.00 |
| Jun 30, 2024 | 3,424.00 |
| Mar 31, 2024 | 1,733.00 |
| Dec 31, 2023 | 4,965.00 |
| Sep 30, 2023 | 4,000.00 |
| Jun 30, 2023 | 3,583.00 |
| Mar 31, 2023 | 6,309.00 |
| Dec 31, 2022 | 4,522.00 |
| Sep 30, 2022 | 4,822.00 |
| Jun 30, 2022 | 3,014.00 |
| Mar 31, 2022 | 1,764.00 |
| Dec 31, 2021 | 5,443.00 |
| Sep 30, 2021 | 6,847.00 |
| Jun 30, 2021 | 13,609.00 |